SU5402

CAS No. 215543-92-3

SU5402 ( SU5402; SU-5402; SU 5402 )

Catalog No. M17435 CAS No. 215543-92-3

SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 53 In Stock
10MG 84 In Stock
25MG 152 In Stock
50MG 255 In Stock
100MG 410 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SU5402
  • Note
    Research use only, not for human use.
  • Brief Description
    SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.
  • Description
    SU5402 is a potent and selective vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR) inhibitor (IC50 values are 0.02, 0.03, 0.51 and > 100 μ M at VEGFR2, FGFR1, PDGFR β and EGFR respectively).
  • Synonyms
    SU5402; SU-5402; SU 5402
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    FGFR1; PDGFRβ; VEGFR2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    215543-92-3
  • Formula Weight
    296.32
  • Molecular Formula
    C17H16N2O3
  • Purity
    98%
  • Solubility
    DMSO : ≥ 30 mg/mL; 101.24 mM
  • SMILES
    CC1=CNC(=C1CCC(=O)O)/C=C\2/C3=CC=CC=C3NC2=O
  • Chemical Name
    (Z)-3-(4-methyl-2-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid.

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Neratinib

    A potent, highly selective, irreversible HER2 and EGFR inhibitor with IC50 of 59 nM and 92 nM in cell-free assays.

  • Gefitinib

    A potent, selective, orally active EGFR inhibitor with IC50 of 23 nM; inhibits EGF-stimulated proliferation of KB cells with IC50 of 80 nM.

  • Afatinib

    An irreversible, dual EGFR/HER2 inhibitor with IC50 of 0.5/0.4/10/14 nM for wt EGFR/EGFR L858R/EGFR L858R+T790M/HER2 respectively.